http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1103155-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1966-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1968-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1103155-A |
| titleOfInvention | Improvements in and relating to quinazolines |
| abstract | Novel compounds of the tautomeric formulae <FORM:1103155/C2/1> and <FORM:1103155/C2/2> wherein each of R1, R2, R3 and R4 is a hydrogen or halogen atom or an alkyl, aryl, nitro or hydroxy group and R is a saturated or unsaturated, substituted or unsubstituted aliphatic, cycloaliphatic or heterocyclic radical or a substituted or unsubstituted aryl radical, are prepared by reacting an o-aminophenylhydroxamic acid of the formula <FORM:1103155/C2/3> with an aldehyde of the formula RCHO or an acylate thereof. The novel compounds may be dehydrated, e.g. by azeotropic distillation or by means of dehydrating agents, into 4-ketoquinazolines of the formula <FORM:1103155/C2/4> Pharmaceutical compositions having bacteriostatic activity, for oral or parenteral administration, comprise one of the above novel compounds together with a carrier. |
| priorityDate | 1965-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.